SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-18-000737
Filing Date
2018-04-24
Accepted
2018-04-24 14:22:50
Documents
3
Period of Report
2018-04-18
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 2.06: Material Impairments
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K medizone8k042318.htm 8-K 24687
2 EX-99.1 ex99-1.htm EX-99 79228
3 EX-99.2 ex99-2.htm EX-99.2 5757
  Complete submission text file 0001185185-18-000737.txt   111334
Mailing Address 350 EAST MICHIGAN AVENUE SUITE 500 KALAMAZOO MI 49007
Business Address 350 EAST MICHIGAN AVENUE SUITE 500 KALAMAZOO MI 49007 (269) 202-5020
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 002-93277-D | Film No.: 18771106
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries